Extract from the Register of European Patents

EP About this file: EP1456404

EP1456404 - A METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.07.2011
Database last updated on 01.04.2026
Most recent event   Tooltip13.09.2013Lapse of the patent in a contracting state
Updated state(s): BG
published on 16.10.2013  [2013/42]
Applicant(s)For all designated states
GENTIUM SPA
Piazza XX Settembre, 2
I-22089 Villa Guardia / IT
[2004/38]
Inventor(s)01 / PORTA, Roberto
Via Aquileia, 1
I-22012 Cernobbio / IT
02 / CATTANEO, Franco
Via G. Verdi 47
I-21055 Gorla Minore / IT
03 / FERRO, Laura
Piazza Brera, 24/6
I-20100 Milano / IT
 [2004/38]
Representative(s)Pistolesi, Roberto, et al
Dragotti & Associati Srl
Via Nino Bixio, 7
20129 Milano / IT
[N/P]
Former [2004/38]Pistolesi, Roberto, et al
Dragotti & Associati SRL Galleria San Babila 4/c
20122 Milano / IT
Application number, filing date02795074.027.11.2002
[2004/38]
WO2002EP13371
Priority number, dateEP2001083077017.12.2001         Original published format: EP 01830770
[2004/38]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03052130
Date:26.06.2003
Language:EN
[2003/26]
Type: A2 Application without search report 
No.:EP1456404
Date:15.09.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 26.06.2003 takes the place of the publication of the European patent application.
[2004/38]
Type: B1 Patent specification 
No.:EP1456404
Date:08.09.2010
Language:EN
[2010/36]
Search report(s)International search report - published on:EP15.01.2004
ClassificationIPC:C12Q1/37, C12Q1/56, G01N33/48
[2004/38]
CPC:
C12Q1/37 (EP,KR,US); A61P7/02 (EP); C12Q1/56 (EP,KR,US);
G01N33/48 (KR); G01N2333/968 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2010/36]
Former [2004/38]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  SK,  TR 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RO06.07.2004
SI06.07.2004
TitleGerman:METHODE ZUR BESTIMMUNG DER BIOLOGISCHEN AKTIVITÄT VON DIFIBROTID[2004/38]
English:A METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE[2004/38]
French:METHODE DE MESURE DE L'ACTIVITE BIOLOGIQUE D'UN DEFIBROTIDE[2004/38]
Entry into regional phase06.07.2004National basic fee paid 
06.07.2004Designation fee(s) paid 
06.07.2004Examination fee paid 
Examination procedure16.07.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
10.06.2004Amendment by applicant (claims and/or description)
06.07.2004Examination requested  [2004/38]
23.10.2006Despatch of a communication from the examining division (Time limit: M04)
30.01.2007Reply to a communication from the examining division
12.03.2007Despatch of a communication from the examining division (Time limit: M06)
02.08.2007Reply to a communication from the examining division
03.12.2009Despatch of a communication from the examining division (Time limit: M04)
18.02.2010Reply to a communication from the examining division
04.06.2010Communication of intention to grant the patent
29.07.2010Fee for grant paid
29.07.2010Fee for publishing/printing paid
Opposition(s)09.06.2011No opposition filed within time limit [2011/33]
Fees paidRenewal fee
26.11.2004Renewal fee patent year 03
25.11.2005Renewal fee patent year 04
24.11.2006Renewal fee patent year 05
26.11.2007Renewal fee patent year 06
25.11.2008Renewal fee patent year 07
19.02.2010Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
30.11.200908   M06   Fee paid on   19.02.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
SK08.09.2010
TR08.09.2010
IE27.11.2010
MC30.11.2010
BG08.12.2010
[2013/42]
Former [2012/47]BG08.09.2010
CY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
SK08.09.2010
TR08.09.2010
IE27.11.2010
MC30.11.2010
Former [2012/41]BG08.09.2010
CY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
SK08.09.2010
IE27.11.2010
MC30.11.2010
Former [2011/47]CY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
SK08.09.2010
IE27.11.2010
MC30.11.2010
Former [2011/31]CY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
SK08.09.2010
MC30.11.2010
Former [2011/23]CY08.09.2010
CZ08.09.2010
EE08.09.2010
FI08.09.2010
SK08.09.2010
Former [2011/13]CY08.09.2010
FI08.09.2010
Former [2011/10]FI08.09.2010
Cited inInternational search[A]   R.PORTA ET. AL.: "High-Performance", ANALYTICAL BIOCHEMISTRY, vol. 204, no. 1, July 1992 (1992-07-01), pages 143 - 146, XP002202053

DOI:   http://dx.doi.org/10.1016/0003-2697(92)90153-X
by applicant  PRINO G.; MANTOVANI M.; NIADA R.; COCCHERI S.; BUTTI A.: "Indagini preliminari sull'attivit fibrinolitica, nell'animale e nell'uomo, di una nuova sostanza presente in diversi organi ani- nzali", SIMPOSIO INTEMAZIONALE: LA RICERCA SCIENTIFICA NELL'INDUSTRIA FARMACEUTICA IN ITALIA, vol. 24, 1969, pages 552 - 561
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.